isoxazoles has been researched along with Leukemia, Myeloid, Acute in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X; Qi, W; Sun, L; Wang, C; Wang, M; Xu, X; Zhao, D | 1 |
Anusha, S; Ashwini, N; Bender, A; Fuchs, JE; Garg, M; Kanojia, D; Koeffler, HP; Madan, V; Mohan, CD; Rakesh, KS; Rangappa, KS; Rangappa, S; Swaroop, TR | 1 |
Chen, LJ; Cheng, C; Li, LL; Ma, S; Niu, T; Wei, YQ; Xiang, R; Xiong, Y; Yang, LL; Yang, SY; Zheng, MW; Zhong, L; Zhou, Q | 1 |
Burnett, AK; Knapper, S; Lazenby, M; Pepper, CJ; Walsby, EJ | 1 |
Chitneni, SR; Moore, JO; Nichols, KE; Weinberg, JB | 1 |
Capizzi, RL; Craig, JB; Powell, BL; Richards, F | 1 |
Baker, MA; Chang, G; Grant, S; Hindenburg, AA; Taub, RN | 1 |
7 other study(ies) available for isoxazoles and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis.
Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA Damage; Dose-Response Relationship, Drug; Humans; Isoxazoles; Leukemia, Myeloid, Acute; Protein-Tyrosine Kinases; Pyrazines; U937 Cells | 2019 |
Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Isoxazoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Triazoles; Tubulin | 2015 |
SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML.
Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; G1 Phase Cell Cycle Checkpoints; Humans; Isoxazoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Phenylurea Compounds; Pyrazoles; Pyrimidines; Urea; Wnt Proteins; Wnt Signaling Pathway; Zebrafish | 2015 |
The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
Topics: Adult; Aged; Aged, 80 and over; Annexin A5; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; HSP90 Heat-Shock Proteins; Humans; I-kappa B Kinase; Isoxazoles; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Resorcinols; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2013 |
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
Topics: Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Isoxazoles; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukocytes; Oxazoles; Reference Values; Tumor Cells, Cultured | 1989 |
Phase I-II trial of acivicin in adult acute leukemia.
Topics: Aged; Antibiotics, Antineoplastic; Drug Evaluation; Humans; Isoxazoles; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Oxazoles | 1988 |
Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
Topics: 3-Deazauridine; Agglutination; Antimetabolites, Antineoplastic; Cell Line; Cytarabine; Cytidine Triphosphate; Doxorubicin; Glucosamine; Humans; Isoxazoles; Lectins; Leukemia, Myeloid, Acute; N-Acetylneuraminic Acid; Pyrimidines; Sialic Acids | 1985 |